Inventiva S.A. ADR (IVA): Price and Financial Metrics
IVA Price/Volume Stats
| Current price | $2.35 | 52-week high | $4.75 |
| Prev. close | $2.37 | 52-week low | $1.53 |
| Day low | $2.29 | Volume | 2,500 |
| Day high | $2.35 | Avg. volume | 70,787 |
| 50-day MA | $2.60 | Dividend yield | N/A |
| 200-day MA | $2.83 | Market Cap | 123.32M |
IVA Stock Price Chart Interactive Chart >
Inventiva S.A. ADR (IVA) Company Bio
Inventiva SA engages in the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis and related diseases. It owns an in-house drug-discovery platform that develops internal oncology and fibrosis discovery pipeline with approaches centred on transcription factors, epigenetics targets, and nuclear receptors. The company was founded by Pierre Broqua and Frédéric Cren on October 27, 2011 and is headquartered in Daix, France.
IVA Price Returns
| 1-mo | -11.65% |
| 3-mo | 14.63% |
| 6-mo | -15.47% |
| 1-year | -48.01% |
| 3-year | -82.92% |
| 5-year | N/A |
| YTD | -47.96% |
| 2023 | 1.26% |
| 2022 | -67.35% |
| 2021 | -5.79% |
| 2020 | N/A |
| 2019 | N/A |
Loading social stream, please wait...